The global Drug-Delivery Smart Pill market size was valued at US$ 127 million in 2024 and is forecast to a readjusted size of USD 315 million by 2031 with a CAGR of 14.1% during review period.
Drug delivery smart pill is an intelligent drug delivery device. It is a pill containing a micro sensor that can autonomously release drug ingredients in the patient"s body and feedback the drug to the patient through signals.
The smart pill"s drug release rate and duration can be programmed and adjusted via an external device to suit different treatment needs. For example, for patients who need to take medication regularly, smart pills can be used to achieve precise drug release, ensuring the accuracy and consistency of medication and improving treatment effects. In addition, smart pills can also monitor the patient"s drug absorption in real time, providing doctors with accurate drug treatment information, allowing doctors to promptly adjust the dosage and type of drugs according to the patient"s condition.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug-Delivery Smart Pill market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug-Delivery Smart Pill market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Drug-Delivery Smart Pill market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Drug-Delivery Smart Pill market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Drug-Delivery Smart Pill market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug-Delivery Smart Pill
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug-Delivery Smart Pill market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CapsoVision, Given Imaging, Medimetrics S.A, Olympus Corporation, Bio-Images Research Limited, Chongqing Jinshan Science & Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Drug-Delivery Smart Pill market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Adult
Children
麻豆原创 segment by Application
Hospital
Clinic
Others
Major players covered
CapsoVision
Given Imaging
Medimetrics S.A
Olympus Corporation
Bio-Images Research Limited
Chongqing Jinshan Science & Technology
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug-Delivery Smart Pill product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug-Delivery Smart Pill, with price, sales quantity, revenue, and global market share of Drug-Delivery Smart Pill from 2020 to 2025.
Chapter 3, the Drug-Delivery Smart Pill competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Delivery Smart Pill breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Drug-Delivery Smart Pill market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Delivery Smart Pill.
Chapter 14 and 15, to describe Drug-Delivery Smart Pill sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Drug-Delivery Smart Pill Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Adult
1.3.3 Children
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Drug-Delivery Smart Pill Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Drug-Delivery Smart Pill 麻豆原创 Size & Forecast
1.5.1 Global Drug-Delivery Smart Pill Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Drug-Delivery Smart Pill Sales Quantity (2020-2031)
1.5.3 Global Drug-Delivery Smart Pill Average Price (2020-2031)
2 Manufacturers Profiles
2.1 CapsoVision
2.1.1 CapsoVision Details
2.1.2 CapsoVision Major Business
2.1.3 CapsoVision Drug-Delivery Smart Pill Product and Services
2.1.4 CapsoVision Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 CapsoVision Recent Developments/Updates
2.2 Given Imaging
2.2.1 Given Imaging Details
2.2.2 Given Imaging Major Business
2.2.3 Given Imaging Drug-Delivery Smart Pill Product and Services
2.2.4 Given Imaging Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Given Imaging Recent Developments/Updates
2.3 Medimetrics S.A
2.3.1 Medimetrics S.A Details
2.3.2 Medimetrics S.A Major Business
2.3.3 Medimetrics S.A Drug-Delivery Smart Pill Product and Services
2.3.4 Medimetrics S.A Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Medimetrics S.A Recent Developments/Updates
2.4 Olympus Corporation
2.4.1 Olympus Corporation Details
2.4.2 Olympus Corporation Major Business
2.4.3 Olympus Corporation Drug-Delivery Smart Pill Product and Services
2.4.4 Olympus Corporation Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Olympus Corporation Recent Developments/Updates
2.5 Bio-Images Research Limited
2.5.1 Bio-Images Research Limited Details
2.5.2 Bio-Images Research Limited Major Business
2.5.3 Bio-Images Research Limited Drug-Delivery Smart Pill Product and Services
2.5.4 Bio-Images Research Limited Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Bio-Images Research Limited Recent Developments/Updates
2.6 Chongqing Jinshan Science & Technology
2.6.1 Chongqing Jinshan Science & Technology Details
2.6.2 Chongqing Jinshan Science & Technology Major Business
2.6.3 Chongqing Jinshan Science & Technology Drug-Delivery Smart Pill Product and Services
2.6.4 Chongqing Jinshan Science & Technology Drug-Delivery Smart Pill Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Chongqing Jinshan Science & Technology Recent Developments/Updates
3 Competitive Environment: Drug-Delivery Smart Pill by Manufacturer
3.1 Global Drug-Delivery Smart Pill Sales Quantity by Manufacturer (2020-2025)
3.2 Global Drug-Delivery Smart Pill Revenue by Manufacturer (2020-2025)
3.3 Global Drug-Delivery Smart Pill Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Drug-Delivery Smart Pill by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Drug-Delivery Smart Pill Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Drug-Delivery Smart Pill Manufacturer 麻豆原创 Share in 2024
3.5 Drug-Delivery Smart Pill 麻豆原创: Overall Company Footprint Analysis
3.5.1 Drug-Delivery Smart Pill 麻豆原创: Region Footprint
3.5.2 Drug-Delivery Smart Pill 麻豆原创: Company Product Type Footprint
3.5.3 Drug-Delivery Smart Pill 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Drug-Delivery Smart Pill 麻豆原创 Size by Region
4.1.1 Global Drug-Delivery Smart Pill Sales Quantity by Region (2020-2031)
4.1.2 Global Drug-Delivery Smart Pill Consumption Value by Region (2020-2031)
4.1.3 Global Drug-Delivery Smart Pill Average Price by Region (2020-2031)
4.2 North America Drug-Delivery Smart Pill Consumption Value (2020-2031)
4.3 Europe Drug-Delivery Smart Pill Consumption Value (2020-2031)
4.4 Asia-Pacific Drug-Delivery Smart Pill Consumption Value (2020-2031)
4.5 South America Drug-Delivery Smart Pill Consumption Value (2020-2031)
4.6 Middle East & Africa Drug-Delivery Smart Pill Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
5.2 Global Drug-Delivery Smart Pill Consumption Value by Type (2020-2031)
5.3 Global Drug-Delivery Smart Pill Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
6.2 Global Drug-Delivery Smart Pill Consumption Value by Application (2020-2031)
6.3 Global Drug-Delivery Smart Pill Average Price by Application (2020-2031)
7 North America
7.1 North America Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
7.2 North America Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
7.3 North America Drug-Delivery Smart Pill 麻豆原创 Size by Country
7.3.1 North America Drug-Delivery Smart Pill Sales Quantity by Country (2020-2031)
7.3.2 North America Drug-Delivery Smart Pill Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
8.2 Europe Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
8.3 Europe Drug-Delivery Smart Pill 麻豆原创 Size by Country
8.3.1 Europe Drug-Delivery Smart Pill Sales Quantity by Country (2020-2031)
8.3.2 Europe Drug-Delivery Smart Pill Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Drug-Delivery Smart Pill 麻豆原创 Size by Region
9.3.1 Asia-Pacific Drug-Delivery Smart Pill Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Drug-Delivery Smart Pill Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
10.2 South America Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
10.3 South America Drug-Delivery Smart Pill 麻豆原创 Size by Country
10.3.1 South America Drug-Delivery Smart Pill Sales Quantity by Country (2020-2031)
10.3.2 South America Drug-Delivery Smart Pill Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Drug-Delivery Smart Pill Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Drug-Delivery Smart Pill Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Drug-Delivery Smart Pill 麻豆原创 Size by Country
11.3.1 Middle East & Africa Drug-Delivery Smart Pill Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Drug-Delivery Smart Pill Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Drug-Delivery Smart Pill 麻豆原创 Drivers
12.2 Drug-Delivery Smart Pill 麻豆原创 Restraints
12.3 Drug-Delivery Smart Pill Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Drug-Delivery Smart Pill and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug-Delivery Smart Pill
13.3 Drug-Delivery Smart Pill Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drug-Delivery Smart Pill Typical Distributors
14.3 Drug-Delivery Smart Pill Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
CapsoVision
Given Imaging
Medimetrics S.A
Olympus Corporation
Bio-Images Research Limited
Chongqing Jinshan Science & Technology
听
听
*If Applicable.
